RecruitingNot ApplicableNCT01945840

Gut Hormones and Roux en Y Gastric Bypass

Do Gut Hormones Mediate the Beneficial Effects of Roux-en-Y Bypass?


Sponsor

Imperial College London

Enrollment

190 participants

Start Date

Oct 1, 2013

Study Type

INTERVENTIONAL

Conditions

Summary

The purpose of this study is to assess whether the changes in gut hormones seen following Roux en Y Gastric Bypass surgery are responsible for some of the beneficial effects seen post-operatively.


Eligibility

Min Age: 18 YearsMax Age: 70 Years

Plain Language Summary

Simplified for easier understanding

This study is examining how gut hormones (the chemical messengers produced in your digestive system) change after a type of weight-loss surgery called Roux-en-Y gastric bypass, to better understand why this surgery helps control blood sugar in people with type 2 diabetes. **You may be eligible if...** - You are scheduled for or have recently had Roux-en-Y gastric bypass surgery - You have been diagnosed with obesity (body mass index above a certain level) - You may or may not have type 2 diabetes - You are between 18 and 65 years old - You are willing to attend study visits and provide blood samples at multiple time points **You may NOT be eligible if...** - You have had prior stomach or intestinal surgery (other than the gastric bypass being studied) - You have serious kidney, liver, or heart disease - You are pregnant or planning to become pregnant during the study - You are using certain medications that affect blood sugar or gut hormones - You have type 1 diabetes Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

PROCEDURERoux en Y Gastric Bypass Surgery
OTHERGut hormone infusion
OTHERPlacebo infusion
OTHERVery low calorie diet

Locations(1)

NIHR/Wellcome Trust Imperial CRF, Hammersmith Hospital

London, Greater London, United Kingdom

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT01945840


Related Trials